President Donald Trump is set to reveal the “framework” of his new health care plan aimed at addressing the rising costs associated with the Affordable Care Act.
Victory RS Mid Cap Growth Fund underperformed in Q3 2025 but sees long-term tech potential. Learn about market trends, Fed ...
Blue Owl Capital (OBDC) terminated its merger with Blue Owl Capital Corporation II, leading to a 20% discount to net asset ...
Discover how Northern Funds International Equity Fund (NOIGX) outperformed its benchmark amid global economic resilience and ...
Discover why Acme United (ACU) is rated 'buy' for long-term value, strong growth plans, and resilient performance.
Discover why Block is a strong buy—learn about growth targets, robust profits, and undervaluation from recent investor day ...
Colgate-Palmolive recently rebounded from a multi-year earnings decline, driven by its 2022 Global Productivity Initiative.
Explore Destiny Tech100 (DXYZ) for pre-IPO access to tech giants like SpaceX. Weigh its high premium and fees before ...
Bristow Group faces offshore energy headwinds but projects 25% EBITDA growth in 2025. See why shares still offer upside and ...
Explore PGIM Balanced Fund's Q3 2025 performance, market review, and economic outlook. Learn more about our strategic asset ...
SPHB targets high-volatility stocks, offering outsized gains in bull markets but significant downside risk in downturns. Read ...
Explore the AMG GW&K Small/Mid Cap Core Fund's Q3 2025 performance. Learn why its focus on consistent earnings led to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results